Can we treat keratoconus without surgery? The development of pharmacological agents that can induce corneal cross-linking through simple eye drops is a major area of pharmaceutical research. These "chemical" cross-linkers aim to mimic the effect of UV-based CXL but with a significantly lower side-effect profile and zero surgical risk. How is the Ophthalmic Drug Delivery Market supporting...